Chongnoi H&D is a Korean medical organization operating specialized clinics that provide patent-protected herbal treatments for dementia and Alzheimer's disease, supported by research published in international scientific journals.
Chongnoi H&D operates a network of Korean medicine clinics, known as Chongnoi Oriental Medicine Clinic, which specialize in the treatment and prevention of dementia and Alzheimer's disease. The organization has developed a proprietary herbal medicine treatment called Cheongnoe-tang, which has been granted a patent for its efficacy in preventing, treating, or improving Alzheimer's disease. This treatment works by utilizing complex herbal extracts that have been scientifically studied for their ability to reduce amyloid-beta plaque accumulation and phosphorylated tau protein levels, which are critical biomarkers in Alzheimer's pathology. The clinical efficacy of these extracts has been documented in peer-reviewed international scientific journals.
By providing evidence-based, integrative treatment options, the clinic aims to support the cognitive health of an aging population. Their approach addresses the significant challenges faced by patients and their families, seeking to improve patient memory, cognitive function, and quality of life. The clinic's research is spearheaded by its affiliated biotechnology laboratory, which focuses on advancing scientific solutions for neurodegenerative conditions. Through a combination of clinical practice and ongoing research, Chongnoi H&D contributes to the management of cognitive health issues, supported by internal assessments and patient outcome monitoring.